Thermo Fisher buys Brammer Bio for $1.7bn
Thermo Fisher is set to acquire Brammer Bio for approximately $1.7 billion.
Read More
Tag: gene therapy deals
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
